ACD Bioscience shortens the path to personalised medicine by unlocking the power of RNA biomarkers.
Advanced Cell Diagnostics, Inc. (ACD) is a leader in the emerging field of molecular pathology, developing cell- and tissue-based diagnostic tests for personalised medicine. Based in the heart of Silicon Valley, ACD was founded and managed by experienced entrepreneurs in the life science industry.
ACD’s products and services are based on its proprietary RNAscope technology – the first multiplex fluorescent and chromogenic in situ hybridisation platform, capable of detecting and quantifying RNA biomarkers in situ at single molecule sensitivity.
RNAscope® Technology is a novel in situ hybridization (ISH) assay for detection of target RNA within intact cells. The assay represents a major advance in RNA ISH approaches with its proprietary probe design to amplify target-specific signals but not background noise from non-specific hybridization.